Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virus

24 Sept 2024

Abstract excerpt

Mpox (formerly known as monkeypox), which has symptoms similar to smallpox, is a zoonotic disease caused by the monkeypox virus (MPXV). From 1 January 2022 to 31 March 2024, 117 countries, territories, or areas reported 95,226 laboratory-confirmed cases of Mpox (including 185 deaths) to the World Health Organization. However, as there is no licensed specific MPXV vaccine available globally, the vaccines currently...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Herpesvirus Infections and Treatments
Share to Plant Virus Research Studies
Share to Poxvirus research and outbreaks

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39321566
DOI: 10.1016/j.vaccine.2024.126384

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Systematic evaluation of the induction of efficient neutralizing antibodies by recombinant multicomponent subunit vaccines against monkeypox virusPMID 39321566Read ↗

Real-world effectiveness of mpox (monkeypox) vaccines: a systematic reviewSemantic proximity Read ↗

Two noncompeting human neutralizing antibodies targeting MPXV B6 show protective effects against orthopoxvirus infectionsSemantic proximity Read ↗

In-silico formulation of a next-generation polyvalent vaccine against multiple strains of monkeypox virus and other related poxvirusesSemantic proximity Read ↗

Comprehensive Profiling of Monkeypox Virus Antigens Identifies Potent Targets for Next-Generation mRNA Vaccine DevelopmentSemantic proximity Read ↗

A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus diseaseSemantic proximity Read ↗

A monkeypox mRNA-lipid nanoparticle vaccine targeting virus binding, entry, and transmission drives protection against lethal orthopoxviral challengeSemantic proximity Read ↗

Novel Multi-Epitope Vaccine candidate derived from critically important proteins of Monkeypox isolatesSemantic proximity Read ↗

A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infectionSemantic proximity Read ↗

Vaccine approach for human monkeypox over the years and current recommendations to prevent the outbreak: a rapid reviewSemantic proximity Read ↗

Multi-Epitope Vaccine for Monkeypox Using Pan-Genome and Reverse Vaccinology ApproachesSemantic proximity Read ↗

Novel Multi Epitope-based Vaccine against Monkeypox Virus: Vaccinomic approachSemantic proximity Read ↗

Immunogenicity of monkeypox virus surface proteins and cross-reactive antibody responses in vaccinated and infected individuals: implications for vaccine and therapeutic developmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.